In terms of demographic characteristics, the number of patients in this study increased significantly after 2015, which was mainly related to the improvement in diagnostic level, especially the immunohistochemical markers of CyclinD1 and Sox11 that were used as routine examinations for the diagnosis of B‐cell lymphoma in large hospitals in China. The gene discussed is CCND1; the disease is B-cell non-Hodgkin lymphoma.